First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo September 14, 2020 Los Angeles Biotechnology Network News News Comments Off on First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--First Patient Enrolled in AVITA Therapeutic’s Pivotal Study Evaluating the RECELL System for Repigmentation of Stable Vitiligo Click to view original post